Economic burden of non-approved alternative therapies among patients with stage IV cancer: A prospective observational study.

Authors
Category Primary study
Conference2026 ASCO Annual Meeting
Year 2026
This article has no abstract
Epistemonikos ID: c36953d9474a343c4b1771f25ff79e617d6d25fa
First added on: Jun 20, 2026